WHO review dismisses concerns of brain cancer risk from mobile phone use; calls for re-evaluation of IARC classification

The findings indicate that despite the surge in wireless technology usage, there has not been a corresponding rise in brain cancer rates. 

Livemint
Published4 Sep 2024, 01:09 PM IST
WHO review dismisses concerns over mobile phone radiation, brain cancer, calls for re-evaluation of IARC classification
WHO review dismisses concerns over mobile phone radiation, brain cancer, calls for re-evaluation of IARC classification(REUTERS)

A new review commissioned by the World Health Organization (WHO) has found no evidence linking mobile phone use with an increased risk of brain cancer. Published on Tuesday, September 3, the review analyzed data from 63 studies conducted between 1994 and 2022, newswire Reuters reported on Wednesday, September 4.

The findings indicate that despite the surge in wireless technology usage, there has not been a corresponding rise in brain cancer rates. This holds true for individuals who frequently make long phone calls or have used mobile phones for over a decade, the findings indicate, according to the Reuters report.

Also Read | What is Mpox? Know symptoms of monkeypox and what to do if you get infection

The review was conducted by 11 researchers from 10 countries, including the Australian government’s radiation protection authority. Co-author Mark Elwood, a professor of cancer epidemiology at the University of Auckland in New Zealand, noted that “none of the major questions studied showed increased risks,” as quoted by the Reuters report.

Also Read | The far-reaching ripple effects of a debunked cancer study

The research evaluated various cancers, including brain cancer in adults and children, as well as cancers of the pituitary gland, salivary glands, and leukaemia, concerning mobile phone use and exposure to radiofrequency from other sources like TV baby monitors and radar.

The review builds on previous findings by the WHO and other international health organizations, which have consistently reported no definitive evidence of harmful health effects from mobile phone radiation. However, as per the Reuters report, they have called for ongoing research.

IARC classifies mobile phone radiation as carcinogenic

The International Agency for Research on Cancer (IARC) currently classifies mobile phone radiation as "possibly carcinogenic" (Class 2B), a designation used when a potential link cannot be ruled out. According to the Reuters report, the IARC advisory group has recommended re-evaluating this classification in light of new data.

Also Read | Dying cancer patient will spend her final moments with the highest bidder

The WHO's detailed evaluation of this issue is expected to be released in the first quarter of next year.

(With inputs from Reuters)

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

MoreLess
First Published:4 Sep 2024, 01:09 PM IST
Business NewsScienceNewsWHO review dismisses concerns of brain cancer risk from mobile phone use; calls for re-evaluation of IARC classification

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Vedanta share price

    483.20
    11:09 AM | 17 OCT 2024
    -3.6 (-0.74%)

    Tata Steel share price

    154.65
    11:09 AM | 17 OCT 2024
    -0.6 (-0.39%)

    Reliance Industries share price

    2,720.25
    11:09 AM | 17 OCT 2024
    12.25 (0.45%)

    State Bank Of India share price

    814.00
    11:09 AM | 17 OCT 2024
    8.15 (1.01%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Coforge share price

    7,120.75
    10:51 AM | 7 OCT 2024
    -2.4 (-0.03%)

    Vijaya Diagnostic Centre share price

    984.80
    10:51 AM | 7 OCT 2024
    -4.15 (-0.42%)

    Dr. Lal Pathlabs share price

    3,408.00
    10:50 AM | 7 OCT 2024
    -86.25 (-2.47%)
    More from 52 Week High

    Bombay Burmah Trading Corporation share price

    2,519.95
    10:51 AM | 7 OCT 2024
    -245.3 (-8.87%)

    Jubilant Ingrevia share price

    728.55
    10:51 AM | 7 OCT 2024
    -65.7 (-8.27%)

    Triveni Engineering & Indus share price

    426.65
    10:51 AM | 7 OCT 2024
    -35.75 (-7.73%)

    Vodafone Idea share price

    9.08
    10:51 AM | 7 OCT 2024
    -0.72 (-7.35%)
    More from Top Losers

    Astrazeneca Pharma India share price

    7,832.35
    10:51 AM | 7 OCT 2024
    399.85 (5.38%)

    Finolex Industries share price

    280.85
    10:51 AM | 7 OCT 2024
    9.2 (3.39%)

    Macrotech Developers share price

    1,206.20
    10:51 AM | 7 OCT 2024
    34.35 (2.93%)

    JK Lakshmi Cement share price

    797.60
    10:51 AM | 7 OCT 2024
    17.2 (2.2%)
    More from Top Gainers

      Recommended For You

        More Recommendations

        Gold Prices

        • 24K
        • 22K
        Bangalore
        77,915.00510.00
        Chennai
        77,921.00510.00
        Delhi
        78,073.00510.00
        Kolkata
        77,925.00510.00

        Fuel Price

        • Petrol
        • Diesel
        Bangalore
        102.86/L0.00
        Chennai
        100.85/L0.10
        Kolkata
        104.95/L0.00
        New Delhi
        94.72/L0.00

        Popular in Science

          HomeMarketsPremiumInstant LoanMint Shorts